Company Data
Pasithea Therapeutics Corp.
Ticker
KTTA
Current Price
$1.28 -6.57%
Market Cap
$1.6M
Price Target
Refer to Report
Volume
155.8K
52wk Range
$1.32 - $9.25
Overview
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.